{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:45:33Z","timestamp":1788482733788,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"PharmaNutra SpA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00520-022-07184-2","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T10:03:22Z","timestamp":1654769002000},"page":"7645-7653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA"],"prefix":"10.1007","volume":"30","author":[{"given":"Andrea","family":"Zuccarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cicognini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Tancredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpiero","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angioletta","family":"Lasagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Caccialanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cavanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Biasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peppina","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danula","family":"Garigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2 Leandro","family":"Alessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Rovati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia Valeria","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Klersy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Pedrazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"issue":"5","key":"7184_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.6004\/jnccn.2012.0064","volume":"10","author":"GM Rodgers III","year":"2012","unstructured":"Rodgers GM III et al (2012) Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw 10(5):628\u2013653. https:\/\/doi.org\/10.6004\/jnccn.2012.0064","journal-title":"J Natl Compr Canc Netw"},{"issue":"Suppl 1","key":"7184_CR2","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.3747\/co.2008.172","volume":"15","author":"BL Melosky","year":"2008","unstructured":"Melosky BL (2008) Erythropoiesis-stimulating agents: benefits and risks in supportive care of cancer. Curr Oncol 15(Suppl 1):S10\u2013S15. https:\/\/doi.org\/10.3747\/co.2008.172","journal-title":"Curr Oncol"},{"key":"7184_CR3","doi-asserted-by":"publisher","unstructured":"Bohlius J, et al (2006) Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev (3):CD003407. https:\/\/doi.org\/10.1002\/14651858.CD003407.pub4","DOI":"10.1002\/14651858.CD003407.pub4"},{"issue":"5","key":"7184_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s12094-021-02580-2","volume":"23","author":"Y Escobar \u00c1lvarez","year":"2021","unstructured":"Escobar \u00c1lvarez Y et al (2021) SEOM clinical guidelines for anaemia treatment in cancer patients (2020). Clin Transl Oncol 23(5):931\u2013939. https:\/\/doi.org\/10.1007\/s12094-021-02580-2","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"7184_CR5","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/cncr.24115","volume":"115","author":"P Pedrazzoli","year":"2009","unstructured":"Pedrazzoli P et al (2009) Iron supplementation and erythropoiesis-stimulatory agents in the treatment of cancer anemia. Cancer 115(6):1169\u20131173. https:\/\/doi.org\/10.1002\/cncr.24115","journal-title":"Cancer"},{"issue":"1","key":"7184_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000496967","volume":"142","author":"GM Rodgers","year":"2019","unstructured":"Rodgers GM et al (2019) The role of intravenous iron in the treatment of anemia associated with cancer and chemotherapy. Acta Haematol 142(1):13\u201320. https:\/\/doi.org\/10.1159\/000496967","journal-title":"Acta Haematol"},{"issue":"2","key":"7184_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/nu13020482","volume":"13","author":"V Natalucci","year":"2021","unstructured":"Natalucci V et al (2021) Cancer related anemia: an integrated multitarget approach and lifestyle interventions. Nutrients 13(2):482. https:\/\/doi.org\/10.3390\/nu13020482","journal-title":"Nutrients"},{"issue":"9","key":"7184_CR8","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1007\/s00520-017-3690-z","volume":"25","author":"A Mafodda","year":"2017","unstructured":"Mafodda A et al (2017) Oral sucrosomial iron versus intravenous iron in anemic cancer patients without iron deficiency receiving darbepoetin alfa: a pilot study. Support Care Cancer 25(9):2779\u20132786. https:\/\/doi.org\/10.1007\/s00520-017-3690-z","journal-title":"Support Care Cancer"},{"issue":"10","key":"7184_CR9","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1200\/JCO.2007.12.2051","volume":"26","author":"P Pedrazzoli","year":"2008","unstructured":"Pedrazzoli P et al (2008) Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alfa. J Clin Oncol 26(10):1619\u20131625. https:\/\/doi.org\/10.1200\/JCO.2007.12.2051","journal-title":"J Clin Oncol"},{"issue":"2","key":"7184_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00432-011-1072-3","volume":"138","author":"F Petrelli","year":"2012","unstructured":"Petrelli F et al (2012) Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials. J Cancer Res Clin Oncol 138(2):179\u2013187. https:\/\/doi.org\/10.1007\/s00432-011-1072-3","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"7184_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/sj.leu.2404562","volume":"21","author":"M Hedenus","year":"2007","unstructured":"Hedenus M et al (2007) Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study. Leukemia 21(4):627\u2013632. https:\/\/doi.org\/10.1038\/sj.leu.2404562","journal-title":"Leukemia"},{"issue":"2","key":"7184_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1634\/theoncologist.12-2-231","volume":"12","author":"DH Henry","year":"2007","unstructured":"Henry DH et al (2007) Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. Oncologist 12(2):231\u2013242. https:\/\/doi.org\/10.1634\/theoncologist.12-2-231","journal-title":"Oncologist"},{"key":"7184_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.med.60.050307.110718","volume":"60","author":"J Glaspy","year":"2009","unstructured":"Glaspy J et al (2009) Erythropoietin in cancer patients. Annu Rev Med 60:181\u2013192. https:\/\/doi.org\/10.1146\/annurev.med.60.050307.110718","journal-title":"Annu Rev Med"},{"key":"7184_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12882-017-0688-1","volume":"18","author":"A Mikhail","year":"2017","unstructured":"Mikhail A et al (2017) Renal association clinical practice guideline on anaemia of chronic kidney disease. BMC Nephrol 18:345. https:\/\/doi.org\/10.1186\/s12882-017-0688-1","journal-title":"BMC Nephrol"},{"issue":"1","key":"7184_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1200\/JCO.2010.30.3644","volume":"29","author":"DP Steensma","year":"2011","unstructured":"Steensma DP et al (2011) Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia. J Clin Oncol 29(1):97\u2013105. https:\/\/doi.org\/10.1200\/JCO.2010.30.3644","journal-title":"J Clin Oncol"},{"issue":"7","key":"7184_CR16","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1200\/JCO.2004.08.119","volume":"22","author":"M Auerbach","year":"2004","unstructured":"Auerbach M et al (2004) Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 22(7):1301\u20131307. https:\/\/doi.org\/10.1200\/JCO.2004.08.119","journal-title":"J Clin Oncol"},{"key":"7184_CR17","doi-asserted-by":"publisher","unstructured":"Macdougall IC, et al (2016) Iron management in chronic kidney disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int 89(1) pp 28-39, ISSN 0085-2538https:\/\/doi.org\/10.1016\/j.kint.2015.10.002","DOI":"10.1016\/j.kint.2015.10.002"},{"issue":"3","key":"7184_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2450\/2019.0207-19","volume":"18","author":"U Salvadori","year":"2020","unstructured":"Salvadori U et al (2020) (2020) Intravenous ferric carboxymaltose is effective and safe in patients with inflammatory rheumatic diseases. Blood Transfus 18(3):176\u2013181. https:\/\/doi.org\/10.2450\/2019.0207-19","journal-title":"Blood Transfus"},{"issue":"Suppl 4","key":"7184_CR19","doi-asserted-by":"publisher","first-page":"iv96","DOI":"10.1093\/annonc\/mdx758","volume":"29","author":"M Aapro","year":"2018","unstructured":"Aapro M et al (2018) Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Ann Oncol 29(Suppl 4):iv96\u2013iv110. https:\/\/doi.org\/10.1093\/annonc\/mdx758","journal-title":"Ann Oncol"},{"issue":"8","key":"7184_CR20","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1182\/bloodadvances.2018030387","volume":"3","author":"J Bohlius","year":"2019","unstructured":"Bohlius J et al (2019) Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO\/ASH clinical practice guideline update. Blood Adv 3(8):1197\u20131210. https:\/\/doi.org\/10.1182\/bloodadvances.2018030387","journal-title":"Blood Adv"},{"key":"7184_CR21","unstructured":"AIOM (2019) Linee guida AIOM 2019 - Gestione della tossicit\u00e0 ematopoietica in Oncologia. pp 1\u201347, 2019"},{"issue":"5","key":"7184_CR22","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1046\/j.1523-1755.2002.00314.x","volume":"61","author":"B Michael","year":"2002","unstructured":"Michael B et al (2002) Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int 61(5):1830\u20131839. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00314.x","journal-title":"Kidney Int"},{"issue":"2","key":"7184_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/ndt\/gfi253","volume":"21","author":"GM Chertow","year":"2006","unstructured":"Chertow GM et al (2006) Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 21(2):378\u2013382. https:\/\/doi.org\/10.1093\/ndt\/gfi253","journal-title":"Nephrol Dial Transplant"},{"key":"7184_CR24","doi-asserted-by":"publisher","first-page":"102837","DOI":"10.1016\/j.critrevonc.2019.102837","volume":"145","author":"H Abdel-Razeq","year":"2020","unstructured":"Abdel-Razeq H et al (2020) Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia. Crit Rev Oncol Hematol 145:102837. https:\/\/doi.org\/10.1016\/j.critrevonc.2019.102837","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"7184_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/ph11040097","volume":"11","author":"S G\u00f3mez-Ram\u00edrez","year":"2018","unstructured":"G\u00f3mez-Ram\u00edrez S et al (2018) Sucrosomial\u00ae iron: a new generation iron for improving oral supplementation. Pharmaceuticals (Basel) 11(4):97. https:\/\/doi.org\/10.3390\/ph11040097","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"7184_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijpharm.2013.06.078","volume":"454","author":"L Yuan","year":"2013","unstructured":"Yuan L et al (2013) Effect of iron liposomes on anemia of inflammation. Int J Pharm 454(1):82\u201389. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.06.078","journal-title":"Int J Pharm"},{"issue":"9","key":"7184_CR27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1080\/10245332.2017.1317990","volume":"22","author":"AP Capra","year":"2017","unstructured":"Capra AP et al (2017) A child with severe iron-deficiency anemia and a complex TMPRSS6 genotype. Hematology 22(9):559\u2013564. https:\/\/doi.org\/10.1080\/10245332.2017.1317990","journal-title":"Hematology"},{"issue":"4","key":"7184_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/ndt\/gfu357","volume":"30","author":"A Pisani","year":"2015","unstructured":"Pisani A et al (2015) Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial. Nephrol Dial Transplant 30(4):645\u2013652. https:\/\/doi.org\/10.1093\/ndt\/gfu357","journal-title":"Nephrol Dial Transplant"},{"key":"7184_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04361-3","author":"G Giordano","year":"2020","unstructured":"Giordano G et al (2020) Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant\/refractory to iron sulfate: a multicentric randomized study. Ann Hematol. https:\/\/doi.org\/10.1007\/s00277-020-04361-3","journal-title":"Ann Hematol"},{"issue":"2","key":"7184_CR30","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3390\/nu13020608","volume":"13","author":"L Bertani","year":"2021","unstructured":"Bertani L et al (2021) Oral sucrosomial iron is as effective as intravenous ferric carboxy-maltose in treating anemia in patients with ulcerative colitis. Nutrients 13(2):608. https:\/\/doi.org\/10.3390\/nu13020608","journal-title":"Nutrients"},{"issue":"1","key":"7184_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12882-020-01716-w","volume":"21","author":"E Riccio","year":"2020","unstructured":"Riccio E et al (2020) Oral Sucrosomial\u00ae iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis. BMC Nephrol 21(1):57. https:\/\/doi.org\/10.1186\/s12882-020-01716-w","journal-title":"BMC Nephrol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07184-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T10:44:59Z","timestamp":1660733099000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07184-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["7184"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07184-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol and all amendments were approved by the appropriate ethics committee at each center. The trial was done in accordance with the protocol, its amendments, the standards of Good Clinical Practice, the Declaration of Helsinki (Edinburgh 2000, with clarification note from Washington, 2002), and the regulations in force in clinical trials (Legislative Decree no. 211 of 06\/24\/03).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants have provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors agreed to publish the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}